By Robert Preidt

HealthDay Reporter

FRIDAY, Sept. four, 2020 (HealthDay Information) — Folks with lupus are not at increased danger of hospitalization from COVID-19 because of to steroidal medications they acquire to reduce immune method activity, a new analyze finds.

And a related analyze found that folks with inflammatory kinds of arthritis — these types of as rheumatoid arthritis — are not a lot more likely to be hospitalized with COVID-19 than folks devoid of arthritis.

Each research ended up led by researchers at NYU Grossman University of Drugs, in New York Metropolis.

The findings “ought to reassure most sufferers, especially those people on immunosuppressant treatment, that they are at no increased danger of getting to be admitted to clinic from COVID-19 than other lupus or arthritis sufferers,” Dr. Ruth Fernandez-Ruiz, co-author of the research, stated in an NYU Langone information launch.

“Folks with lupus or inflammatory arthritis have the same danger variables for getting critically unwell from COVID-19 as folks devoid of these disorders,” stated Fernandez-Ruiz, a postdoctoral fellow in rheumatology.

Lupus and ailments like rheumatoid arthritis, psoriatic arthritis and spondyloarthritis are autoimmune health conditions in which the immune method mistakenly attacks a person’s have tissues. This results in inflammation in the joints, pores and skin, kidneys and other areas of the system.

The researchers found that lupus sufferers taking immune-suppressing medications — these types of as mycophenolate mofetil (CellCept) and azathioprine (Imuran) — had no increased danger of hospitalization (fifteen out of 24) than lupus sufferers not employing the medications (nine of seventeen).

In addition, the COVID-19 hospitalization level for folks with inflammatory arthritis (26%) was identical to that of New York Metropolis people overall (twenty five%).

An additional obtaining was that sufferers taking biologic medication for arthritis, these types of as adalimumab (Humira) and etanercept (Enbrel), or the antiviral hydroxychloroquine, had no increased or lessen danger of COVID-19 hospitalization than those people not taking the medication.

But sufferers who took steroids identified as glucocorticoids, even in delicate doses, had a ten times increased danger of COVID-19 hospitalization than those people who failed to acquire steroids. Whilst the obtaining is statistically important, the study’s tiny dimension may overestimate the real danger, the researchers observed.

The research ended up recently published on the internet in the journal Arthritis and Rheumatology.

WebMD Information from HealthDay

Sources

Supply: NYU Langone, information launch, Aug. twenty five, 2020



Copyright © 2013-2020 HealthDay. All rights reserved.